Target intelligence / Profile preview

RNA, U6 small nuclear 935, pseudogene (RNU6-935P)

Target
RNU6-935P
Molecular classification
Other
01

Overview

RNU6-935P is a **pseudogene** sequence of the U6 small nuclear RNA (snRNA) gene family. U6 snRNA is a key non-coding RNA involved in pre-mRNA splicing as a component of the spliceosome[1][3], but RNU6-935P itself, being annotated as a pseudogene, is not transcribed into a functional RNA or protein. Pseudogenes such as RNU6-935P may arise from retrotransposition events (often mediated by LINE elements) that create non-functional duplicates of snRNA genes in the genome[2]. These copies generally do not have a biological function, are not involved in disease pathways, and are not considered drug targets or biomarkers. They serve primarily as indicators of genome evolution and retrotransposition activity[2][5]. **Clarifications and essential context:** - **Pseudogene status**: RNU6-935P is a processed pseudogene related to the U6 snRNA. Pseudogenes are generally *non-functional genetic elements*; they **do not encode active biomolecules**, and thus are not valid therapeutic targets, receptors, enzymes, or biomarkers[2][5]. - **U6 snRNA** itself (the functional gene, not the pseudogene) is a non-coding RNA central to the splicing of pre-mRNA in the spliceosome, highly conserved and essential for splicing activity[1][3]. Numerous U6-derived pseudogenes exist throughout vertebrate genomes[1][2]. - **No known role in disease or drug action:** There is no evidence that RNU6-935P participates in pathophysiology, interacts with drugs, or serves any diagnostic or monitoring function.

Other names
RNU6-935PRNA, U6 small nuclear 935, pseudogene

Beyond the preview

Go deeper on RNA, U6 small nuclear 935, pseudogene (RNU6-935P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 935, pseudogene (RNU6-935P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call